Skip to content

MRKR - Marker Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchM

Marker Therapeutics Inc

MRKR · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

M

MRKRMarker Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 23

52-wk high: $2.46
52-wk low: $0.81
Prev close: $1.66
Mkt cap: $23.2M
Beta: 1.51
P/S: 8.6x

Smart money

7 funds hold a position.

Real smart money

Funds holding this stock

7 holders

Combined position$537K

JS
Jim Simons
Q2 2026 13F
$367K
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 13, 2026

Earnings came in 64.0% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $23M

Valuation

P/S8.63
P/B1.67

Quality

Operating margin-386.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: MRKR
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $23.18M
Beta: 1.51

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

1.7x

Profit margin

+0.0%

Op margin

-386.0%

ROE

-76.9%

$88K

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$48K

position

4 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 4 holders

Coverage gaps for MRKR

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.09+64.0%

-$0.25 expected

Next report

What the street expects next

EPS expected

-$0.12

-$0.12 to -$0.12

Revenue expected

$682.0K

3 analysts

Estimate drift

+0.01

Change in 30 days

-76.9%

ROA-44.1%

Growth

Beta1.51